Detalles de la búsqueda
1.
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours.
Br J Cancer
; 124(2): 391-398, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33020594
2.
A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer.
Invest New Drugs
; 38(5): 1588-1597, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32246224
Resultados
1 -
2
de 2
1
Próxima >
>>